Carmot Therapeutics, Inc.
409 Illinois Streeet
San Francisco, CA 94158
info
Chemotype Evolution is a patent pending technology that was invented by Drs. Stig K. Hansen and Daniel A. Erlanson while they were working at Sunesis Pharmaceuticals. Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing the technology. Carmot has licensed the technology and fragment libraries from Sunesis, and Carmot is in the process of further expanding the capabilities of Chemotype Evolution.
Carmot is currently applying Chemotype Evolution to internal targets and is seeking screening collaborations with interested parties. Carmot is offering to work with partners to apply Chemotype Evolution on a fixed-fee basis to their targets of interest.
Carmot Therapeutics, Inc.
409 Illinois Streeet
San Francisco, CA 94158
info